Navigation Links
Evolution of human genome's 'guardian' gives people unique protections from DNA damage
Date:1/16/2008

onary changes in their function. The 14 species represented an estimated 500 million years of evolutionary separation, helping investigators determine how the function of p53 response elements was conserved or changed as different species developed. Dr. Jegga said researchers were surprised to find the acquisition of functional response for certain genes involved in DNA metabolism or repair to be mostly unique in humans. While the functional ability of some genes is shared with chimpanzees and rhesus monkeys, researchers said DNA metabolism and repair function it is not shared at all with rodents.

In humans, when DNA damage is detected, the p53 network seems to have gained additional capabilities that allow it to slow cell growth, initiate repairs or, if needed, apoptotic cell death. Apoptotic, or programmed cell death capability in the p53 network, is thought to be evolutionarily conserved throughout the development of vertebrate species and was probably established after the divergence of vertebrates and non-vertebrates. DNA metabolism and repair capabilities controlled by p53 may have emerged more recently in evolutionary history to create primate-specific response characteristics, the researchers explained.

The fact that DNA metabolism and repair genes have undergone this kind of evolution in humans may reflect an increased need for coordinated control of molecular repair activities during DNA replication to allow for the maintenance of genomic integrity during complex differentiation, growth, and aging, said Bruce Aronow, Ph.D., co-director of Computational Medicine at Cincinnati Childrens and a study co-author.

That different strategies to guard our chromosome structures and DNA sequences against damage are subject to evolutionary adaptation is also suggested by other knowledge we have, Dr. Aronow explained. For example, compared to rodents humans have much shorter telomeres, which are regions of highly repetitive DNA at the end of
'/>"/>

Contact: Nick Miller
513-803-6035
Cincinnati Children's Hospital Medical Center
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Local Oncology Group Leads Online Effort to Revolutionize Cancer Care
2. Join the Vitamin D Revolution: How to Get 30 Minutes of Daily Sunshine for Optimal Health
3. VIDEO from Medialink and Revolution Health: RevolutionHealth.com Launches Resolutions 2.0
4. UCLA Program Aims to Revolutionize Kidney Transplants
5. Prescription for an electronic revolution?
6. Adapting to pregnancy played key role in human evolution, study shows
7. Evolution Tips the Balance in Moms Favor
8. Informed Medical Communications Sells Consumer Internet Division to Revolution Health
9. Chinas Anti-Aging Revolution
10. New Low-Impact Cosmetic Surgery Treatments Revolutionizing Industry
11. ILC Dover Launches Revolutionary ArmorFlex (R) Pharmaceutical Product Contact Film
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/12/2008)...2 /PRNewswire-USNewswire/ -- Baptist Health South,...n Miami, has agreed to,pay the United States $7,77...Claims Act and the Stark Statute between 2003 and ...ogy group that was a source of patient,referrals t...stice,announced today. The payments were made purs...
(Date:5/12/2008)...h., May 12 /PRNewswire-USNewswire/ -- Michael A.,S...st, was installed as,president of the 15,000 membe... 143rd annual meeting of the MSMS House of Delegat...ne State University School of Medicine, Doctor,San...ic Radiology at Henry,Ford Hospital and currently ...
(Date:5/12/2008)... NASDAQ: CRME TSX: COM, VANCOUVER, May 12 /P...AQ: CRME / TSX: COM) today announced that it will ...2008 on the afternoon of Tuesday, May 13,2008. Ca... at 4:30pm,Eastern (1:30pm Pacific) on that day to...all, please dial 416-641-6117 or,866-299-6655. The...
(Date:5/12/2008)...lif., May 12 /PRNewswire-FirstCall/ -- MAP,Pharmac...nancial results for,the first quarter ended March ...ed March 31, 2008 was $14.3,million compared with ...,March 31, 2008, MAP Pharmaceuticals had cash, cas...million., First Quarter Financial Results, Resea...
Breaking Medicine News(10 mins):Health News:Florida Hospital Group Pays U.S. $7,775,000 to Settle False Claims Act Allegations 2Health News:Michael A. Sandler, MD, Installed as President of Michigan State Medical Society 2Health News:Cardiome To Release 2008 First Quarter Results 2Health News:Cardiome To Release 2008 First Quarter Results 3Health News:Cardiome To Release 2008 First Quarter Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 5
...mercials for ‘Head and Shoulders’ Shampoo, that cl...products, is required to be// modified. Adverts f...mpoo are the ones working up more soap than requir...ad & Shoulders, has clarified its stance, insistin...
...ur men whose lives took a turn for the worse after.../ TeGenero and medical research company Parexel, h.... Martin Day, who is handling the case, has felt i...d attempts to solicit information about the tests ...
...are to be believed, reducing calories may well ext...// which appears in this week's Journal of the Ame...uthor Dr. Eric Ravussin, from Louisiana State Univ...nce already exists to suggest that calorie restric...
...the risk of coronary heart attack and could in gen...ated. A 10-year study of 4,400 men and women aged ...aconess Medical Centre in Boston found a link betw...e likelihood of heart disease, reported the online...
Other Medicine News:Health News:Cut down on food to live longer!!! 2
(Date:5/12/2008)...NTA, May 12 /- GeoVax Labs,...d HIV/AIDS vaccine development,company, announced ...n,stock purchase agreement with Fusion Capital Fun..., The Company may sell up to $10 million of its c...er a 25-month period after the Securities and,Exch...
(Date:5/12/2008)...ides the Optimal Combination of Scaffolding, Deliv...bility, TEL AVIV, Israel, May 12 /- ...CE Mark for its Presillion(TM) CoCr Coronary Stent...ions with a technologically,innovative flexible cl... the superb scaffolding the unprecedented,balance ...
(Date:5/12/2008)...ADELPHIA, May 12 /PRNewswire-USNewswire/ -- GlaxoS...International Group (BIG), a leading,academic brea...groups, the,Spanish Breast Cancer Cooperative Grou...hase III study that will examine the role of TYKER...ALTTO (Neoadjuvant Lapatinib and/or,Trastuzumab Tr...
(Date:5/9/2008)..., Fla., May 9 /PRNewswire-USNewswire/ -- Osteoarth...ndition that affects almost 50,million people in t...,cartilage in bone joints. The novel investigation...oral analgesic, provided significant relief,for pa...treated with,placebo, and with fewer gastrointesti...
Breaking Medicine Technology:GeoVax Secures $10 Million Financing Commitment 2GeoVax Secures $10 Million Financing Commitment 3Medinol Receives CE Mark for Presillion(TM) Cobalt Chromium Coronary Stent on Rx System, an Advanced Evolution of the NIR(R) Family of Stents 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Friends of Warren Zevon To Play at Maverick Saloon Raising Awareness of Asbestos Cancer Mesothelioma 5200 1Friends of Warren Zevon To Play at Maverick Saloon Raising Awareness of Asbestos Cancer Mesothelioma 5200 2West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 1West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 2West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 3West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 4West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 5West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 6West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 7West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 8West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 9West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 10West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 11West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 12West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 13West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 14West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 15West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 16West Pharmaceutical Services Announces Third Quarter 2007 Results 5198 17United Therapeutics Reports Third Quarter 2007 Financial Results 1642 1United Therapeutics Reports Third Quarter 2007 Financial Results 1642 2United Therapeutics Reports Third Quarter 2007 Financial Results 1642 3United Therapeutics Reports Third Quarter 2007 Financial Results 1642 4United Therapeutics Reports Third Quarter 2007 Financial Results 1642 5United Therapeutics Reports Third Quarter 2007 Financial Results 1642 6United Therapeutics Reports Third Quarter 2007 Financial Results 1642 7United Therapeutics Reports Third Quarter 2007 Financial Results 1642 8United Therapeutics Reports Third Quarter 2007 Financial Results 1642 9Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 1Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 2Neurocrine Biosciences and Dainippon Sumitomo Pharma 28DSP 29 Announce Agreement to Develop and Commercialize Indiplon in Japan 1640 3
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively, right up until the definitive implants are to be put i
Tibial distractor
...werSuite™ holmium laser combines excellent c...ecise, virtually bloodless procedures. It is also ...l bladder stones of all compositions, making it an...er light is transmitted through flexible fibers, i...
...werSuite™ holmium laser combines excellent c...ecise, virtually bloodless procedures. It is also ...l bladder stones of all compositions, making it an...er light is transmitted through flexible fibers, i...
Medicine Products: